Nifty 50
Tools & Calculators
Stocks
F&O
Mutual Funds
Sector: Pharmaceuticals & Biotechnology
|Small Cap
GUJTHEM
₹372
₹369.35
₹385.65
₹225.05
₹479.00
Markets Today
Historical Performance
As of 20-08-2026 05:33, Gujarat Themis Biosyn Ltd. share price today is ₹0, with a change of ₹-371.30 (-100.00%) from the previous close of ₹371.3. The stock opened at ₹374.25 and traded between ₹369.35 and ₹385.65, with a total traded volume of 189017 shares. The company has a market capitalization of ₹4045.9 Cr in the Pharmaceuticals & Biotechnology sector. while its 52-week high and low are ₹479 and ₹225.05, respectively.
Gujarat Themis Biosyn Ltd. valuation metrics include a P/E ratio of 83.1, and book value of ₹14.10. Profitability indicators show ROE of 16.22% along with a dividend yield of 0.2%. Gujarat Themis Biosyn Ltd. has reported revenue of ₹173.74 Cr and net profit of ₹48.69 Cr.
Gujarat Themis Biosyn Ltd. technical indicators include Day RSI at 55.89, Day MFI at 37.98, Day ADX at 12.68. Additional indicators include Commodity Channel Index (CCI) at 150.7 and Williams %R at -26.88. Momentum indicators show Day MACD at -3.76, Day MACD Signal Line at -5.11, DayATR at 14.21. Rate of Change indicators for Gujarat Themis Biosyn Ltd. include ROC125 at 16.52 and ROC21 at 2.02.
Exponential moving averages include EMA5 at ₹358.6, EMA10 at ₹357.6, EMA12 at ₹357.8, EMA20 at ₹359.7, EMA26 at ₹361.5, EMA50 at ₹364.8, EMA100 at ₹362.7, EMA200 at ₹356.1. Simple moving averages include SMA5 at ₹354.2, SMA10 at ₹357.5, SMA20 at ₹356.8, SMA30 at ₹361.7, SMA50 at ₹372.5, SMA100 at ₹357.1, SMA150 at ₹345, SMA200 at ₹364.6.
Support levels for Gujarat Themis are placed at First Support ₹354.53, Second Support ₹337.77, Third Support ₹326.53. Resistance levels are seen at First Resistance ₹382.53, Second Resistance ₹393.77, Third Resistance ₹410.53. Gujarat Themis Biosyn Ltd. shareholding pattern shows promoter holding at 70.86%, FII holding at 1.76%, DII holding at 0%, public holding at 26.18%.
Indicator | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 |
|---|---|---|---|---|---|
| Total Revenue | 43.79 | 44.23 | 43.37 | 42.35 | 35.87 |
| Operating Expense | 23 | 24.87 | 22.06 | 21.41 | 21.95 |
| Operating Profit | 20.79 | 19.36 | 21.31 | 20.94 | 13.92 |
| Depreciation | 3.97 | 4.04 | 3.89 | 2.96 | 2.03 |
| Interest | 1.79 | 1.91 | 0.96 | 0.04 | 0.04 |
| Tax | 4.10 | 3.45 | 4.41 | 4.50 | 3.06 |
| Net Profit | 11.07 | 10.89 | 12.46 | 14.26 | 9.06 |
₹372.00
↗ Bullish Moving Average
15
↘ Bearish Moving Average
1
| Held By | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|
| Promoter | 70.9 | 70.9 | 70.9 | 70.9 | 70.9 | 70.9 |
| FII | 1.9 | 2.5 | 3 | 2 | 1.8 | 1.8 |
| DII | 1.2 | 1.2 | 1.1 | 1.1 | 1.2 | 1.1 |
| Public | 26 | 25.4 | 25 | 26 | 26.2 | 26.2 |
| Period | Combined Delivery Volume | NSE+BSE Traded Volume Avg | Daily Avg Delivery Volume % |
|---|---|---|---|
| Day | 1.35 L | 2.78 L | 48.56% |
| Week | 54.71 K | 99.05 K | 55.23% |
| 1 Month | 38.75 K | 88.52 K | 43.77% |
| 6 Month | 77.51 K | 2.42 L | 32.03% |
Benjamin Graham Value Screen
Price crossing above SMA20 today, and greater than SMA5
Expensive Performers (DVM)
High Momentum Scores (Technical Scores greater than 50)
Good quarterly growth in the recent results
Relative Outperformance versus Industry over 1 Week
Growth in Net Profit with increasing Profit Margin (QoQ)
RSI indicating price strength
High Volume, High Gain
Biggest Price Gainers from Open
Top Gainers
High Volume, High Gain
Volume Shockers
Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
| 04 Sep, 2025 | 0.67 | FINAL | 05 Sep, 2025 | Equity Share |
| 15 Jul, 2024 | 0.25 | FINAL | Equity Share | |
| 22 Feb, 2024 | 0.75 | INTERIM | 22 Feb, 2024 | Equity Share |
| 01 Sep, 2023 | 1 | FINAL | Equity Share | |
| 01 Dec, 2022 | 4.4 | INTERIM | 02 Dec, 2022 | Equity Share |
| 29 Aug, 2022 | 4 | FINAL | Equity Share | |
| 24 Nov, 2021 | 2 | INTERIM | 25 Nov, 2021 | Equity Share |
| 24 Nov, 2021 | 5 | SPECIAL | 25 Nov, 2021 | Equity Share |
| 10 Sep, 2020 | 1.65 | FINAL | Equity Share |
Financials | ||||||
|---|---|---|---|---|---|---|
| Price (₹) | ₹542 | ₹5.67 | ₹172.10 | ₹14.41 | ₹499.05 | ₹91.99 |
| % Change | -0.01% | 5.00% | -0.11% | -1.50% | 2.21% | 1.25% |
| Revenue TTM (₹ Cr) | ₹526.28 | ₹69.99 | ₹291.17 | ₹226.23 | ₹511.48 | ₹305.93 |
| Net Profit TTM (₹ Cr) | ₹20.77 | ₹-176.47 | ₹14.68 | ₹31.63 | ₹53.97 | ₹16.01 |
| PE TTM | 115.30 | -0.30 | 45.60 | 2.50 | 26.20 | 30.80 |
| 1 Year Return | 38.28 | 440 | 36.74 | 60.77 | -31.24 | 0.99 |
| ROCE | 3.56 | -56.37 | - | 17.36 | 23.87 | 0.77 |
Sigachi Industries Ltd.
₹ 29.00
-2.06%
Windlas Biotech Ltd.
₹ 959.00
+4.47%
Vineet Laboratories Ltd.
₹ 37.90
+4.32%
Solara Active Pharma Sciences Ltd.
₹ 549.00
-0.01%
Zim Laboratories Ltd.
₹ 120.00
+4.79%
Medico Remedies Ltd.
₹ 43.00
+0.80%
Dishman Carbogen Amcis Ltd.
₹ 171.25
+1.25%
Lasa Supergenerics Ltd.
₹ 6.95
-3.34%
Advanced Enzyme Technologies Ltd.
₹ 306.00
+0.99%
Bajaj Healthcare Ltd.
₹ 318.00
-1.32%
Ortin Global Ltd.
₹ 15.49
-1.90%
Brooks Laboratories Ltd.
₹ 59.10
+0.27%
RPG Life Sciences Ltd.
₹ 2674.60
-1.04%
Bafna Pharmaceuticals Ltd.
₹ 242.55
-2.00%
Alpa Laboratories Ltd.
₹ 61.24
-2.11%
SMS Pharmaceuticals Ltd.
₹ 356.00
-0.93%
Nectar Lifesciences Ltd.
₹ 10.57
-1.77%
Mangalam Drugs and Organics Ltd.
₹ 27.00
-3.54%
Indoco Remedies Ltd.
₹ 216.50
-2.11%
Ind-Swift Laboratories Ltd.
₹ 323.50
-6.74%
Lincoln Pharmaceuticals Ltd.
₹ 618.00
-0.18%
Panacea Biotec Ltd.
₹ 403.70
-0.53%
Medicamen Biotech Ltd.
₹ 227.00
+0.56%
Themis Medicare Ltd.
₹ 104.90
-1.80%
By signing up I certify terms, conditions & privacy policy